Adjuvant Global Health Technology Fund, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX)

Filing Manager
Adjuvant Global Health Technology Fund, L.P.
Reporting Manager
Adjuvant Capital GP, L.P.
Security
AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
ANTX
Shares outstanding
30,044,304 shares
Disclosed Ownership
2,373,500 shares
Ownership
7.9%
Form type
SCHEDULE 13G/A
Filing time
28 Feb 2025, 19:57:57 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adjuvant Global Health Technology Fund, L.P. 6.7% 1,995,958 0 1,995,958 /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Global Health Technology Fund DE, L.P. 1.3% 377,542 0 377,542 /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Capital GP, L.P. 7.9% 2,373,500 0 2,373,500 /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Capital Management, L.L.C. 7.9% 2,373,500 0 2,373,500 /s/ Kabeer Aziz Vice President and Secretary